Voloridge Investment Management
LOXO

Voloridge Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Voloridge Investment Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-52,524
Closed -$9.11M – 530
2018
Q2 		$9.11M Buy
52,524
+44,653
+567% +$6.71M 0.24% 98
2018
Q1 		$908K Buy
+7,871
New +$837K 0.02% 373
2017
Q4 		– Sell
-47,050
Closed -$4.33M – 656
2017
Q3 		$4.33M Buy
47,050
+14,201
+43% +$1.1M 0.1% 203
2017
Q2 		$2.63M Buy
+32,849
New +$1.82M 0.07% 246

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Voloridge Investment Management's LOXO Position: Q3 2018 in Review

Voloridge Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 52,524 shares — an estimated $9.11M sold.

Voloridge Investment Management first reported a position in LOXO in Q2 2017 and held it in 4 quarters. The position peaked at $9.11M in Q2 2018. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

  • Voloridge Investment Management reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
  • Voloridge Investment Management sold 52,524 Loxo Oncology, Inc shares in Q3 2018, an estimated $9.11M.
  • Voloridge Investment Management first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 4 quarters.
  • Voloridge Investment Management's Loxo Oncology, Inc position peaked at $9.11M in Q2 2018.
  • 228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on Voloridge Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.